Patents by Inventor C. Dorey

C. Dorey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ocular formulations with neuroprotectants to reduce Alzheimer and neurotoxic risks created by large zinc dosages
    Publication number: 20060039954
    Abstract: Formulations marketed to elderly consumers for preventing or treating age-related eye diseases such as macular degeneration are modified in various four ways, compared to the formulations tested in the first “Age-Related Eye Disease Study” (AREDS-1) clinical trial. Zinc dosages are substabtially reduced, to reduce the risk of Alzheimer's disease and other neurotoxic damage in the brains of elderly people, and zeaxanthin is substituted for a substantial portion of any beta-carotene. Additional useful agents are also disclosed.
    Type: Application
    Filed: May 18, 2005
    Publication date: February 23, 2006
    Inventors: Dennis Gierhart, C. Dorey, Patrick Kelly
  • GFAP-based gene therapy for treatment of retinal diseases
    Publication number: 20050261234
    Abstract: Compositions and methods for reducing neovascularization. Purified nucleic acid constructs and vectors encoding an anti-angiogenic protein operably linked to a GFAP promoter. Vectors can include at least one hypoxia regulated element, enhancer element and silencer element. Gene therapy methods for reducing, delaying or preventing neovascularization based on the nucleic acid constructs and vectors.
    Type: Application
    Filed: April 22, 2005
    Publication date: November 24, 2005
    Applicant: Florida Atlantic University
    Inventors: C. Dorey, Janet Blanks, Howard Prentice